Follow-up surveillance among colorectal cancer survivors of different sexual orientations.

Autor: Boehmer U; Department of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown Center, Boston, MA, 02118, USA. boehmer@bu.edu., Potter J; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; The Fenway Institute, Boston, MA, USA., Clark MA; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.; Brown University School of Public Health, Providence, RI, USA., Winter M; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA., Berklein F; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA., Ceballos RM; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hartshorn K; Boston University School of Medicine, Boston, MA, USA., Ozonoff A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.
Jazyk: angličtina
Zdroj: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2022 Apr; Vol. 16 (2), pp. 445-454. Date of Electronic Publication: 2021 Apr 14.
DOI: 10.1007/s11764-021-01039-1
Abstrakt: Purpose: The purpose of this study was to examine receipt of follow-up surveillance among sexual minority and heterosexual survivors and identify survivor-, physician-, and practice-level characteristics associated with follow-up surveillance.
Methods: An average of 3 years after their stage I-III colorectal cancer diagnosis, we recruited survivors from four cancer registries. A questionnaire, which queried about sexual orientation and other eligibility criteria, was mailed to all cancer survivors. Subsequently, 418 eligible survivors without recurrent disease participated in a telephone survey. Colorectal cancer-specific follow-up surveillance was defined as colonoscopy, carcinoembryonic antigen (CEA) test, or imaging test. We used logistic regression with forward selection to obtain models that best explained each follow-up test.
Results: About 10% of survivors received no follow-up surveillance, while 70% had colonoscopies. While survivors irrespective of sexual orientation received follow-up surveillance, sexual minority survivors had 3 times the odds of receiving imaging tests compared to heterosexual survivors. Having a designated provider of any specialty was most salient for the receipt of surveillance.
Conclusions: Sexual minority survivors' greater receipt of imaging tests may indicate providers perceive them at greater risk for recurrence than heterosexual survivors. Future studies need to examine provider behaviors towards monitoring colorectal cancer survivors of diverse sexual orientations.
Implications for Cancer Survivors: Guidelines recommend surveillance of colorectal cancer survivors to improve survival. This study showed that having a designated provider for follow-up is most salient for the receipt of surveillance, most survivors receive surveillance, and sexual minority survivors had more imaging tests compared to heterosexual survivors.
(© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: